P&G Announces Fiscal Year 2021 Third Quarter Results

Rhea-AI Summary

The Procter & Gamble Company (NYSE: PG) reported Q3 FY21 net sales of $18.1 billion, a 5% increase year-over-year. Organic sales rose 4%, with significant growth in Home Care, Oral Care, and Appliances. Diluted EPS reached $1.26, a 13% increase, while operating cash flow was $4.1 billion. P&G returned $5 billion to shareholders, including a 10% dividend increase, marking 65 years of consecutive dividend hikes. The company maintains sales growth guidance of 5-6% for FY21, with GAAP EPS growth expected at 8-10%.

Positive

• Q3 FY21 net sales increased 5% to $18.1 billion.
• Organic sales growth of 4%, driven by higher-priced categories.
• Diluted EPS rose 13% to $1.26, reflecting strong operational performance.
• Free cash flow productivity reached 106%.
• $5 billion returned to shareholders, including a $2 billion dividend.
• Maintained fiscal 2021 sales growth guidance of 5-6%.

Negative

• Headwinds of approximately $150 million after-tax from foreign exchange impacts.
• Higher freight costs expected to exceed $200 million after-tax.
• Commodity costs headwind projected at $125 million after-tax.

The Procter & Gamble Company (NYSE:PG) reported third quarter fiscal year 2021 net sales of $18.1 billion, an increase of five percent versus the prior year. Excluding the impacts of foreign exchange, acquisitions and divestitures, organic sales increased four percent. Diluted net earnings per share were $1.26, an increase of 13% versus prior year reported EPS and eight percent versus prior year Core EPS.

Operating cash flow was $4.1 billion for the quarter. Free cash flow productivity was 106%. The Company returned $5 billion of cash to shareholders via $2 billion of dividend payments and $3 billion of common stock repurchases. Earlier this month, P&G announced a 10% increase in the quarterly dividend, marking the 65th consecutive year the Company has increased its dividend. P&G has been paying a dividend for 131 consecutive years since its incorporation in 1890.

“We delivered another quarter of solid top-line, bottom-line and cash results in what continues to be a challenging operating environment,” said David Taylor, Chairman, President and Chief Executive Officer. “We remain focused on executing our strategies of superiority, productivity, constructive disruption and improving P&G’s organization and culture. These strategies enabled us to build strong business momentum before the COVID crisis and accelerate our progress during the crisis, and they remain the right strategies to deliver balanced growth and value creation over the long term.”

January - March Quarter Discussion

Net sales in the third quarter of fiscal year 2021 were $18.1 billion, a five percent increase versus the prior year. Favorable foreign exchange increased net sales for the quarter by one percentage point. Excluding the impacts of foreign exchange, acquisitions and divestitures, organic sales increased four percent, driven by two percentage points of increased pricing and two percentage points of positive mix impact. Positive mix was driven by the disproportionate growth of the higher-priced Home Care, Oral Care and Appliances categories and the North America and Greater China regions. Shipment volumes were unchanged versus the prior year.

January - March 2021		Volume		Foreign Exchange		Price		Mix		Other (2)		Net Sales			Organic Volume		Organic Sales
Net Sales Drivers (1)
Beauty		2%		2%		2%		3%		—%		9%			2%		7%
Grooming		—%		—%		2%		2%		—%		4%			—%		4%
Health Care		—%		1%		—%		3%		—%		4%			—%		3%
Fabric & Home Care		3%		1%		2%		2%		—%		8%			3%		7%
Baby, Feminine & Family Care		(4)%		1%		2%		1%		—%		—%			(4)%		(1)%
Total P&G		—%		1%		2%		2%		—%		5%			—%		4%

(1)		Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2)		Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

• Beauty segment organic sales increased seven percent versus year ago. Skin and Personal Care organic sales increased high single digits primarily driven by positive mix impact from growth of super premium SK-II brand, premium innovation in North America Skin Care and increased pricing. Hair Care organic sales increased high single digits led by Greater China due to innovation, distribution growth and a low base period due to pandemic-related shutdowns. Devaluation-related price increases also contributed to Hair Care sales growth.
• Grooming segment organic sales increased four percent versus year ago. Appliances organic sales increased more than 20% due to increased demand for at-home shaving and styling products, innovation and increased pricing. Shave Care organic sales were unchanged as devaluation related price increases and growth in female blades and razors were offset by consumption declines in male blades and razors due to decreased shave frequency.
• Health Care segment organic sales increased three percent for the quarter. Oral Care organic sales increased high single digits driven by innovation and the positive mix impacts of premium products growth. Personal Health Care organic sales decreased mid-single digits primarily due to pandemic-related increases in consumer and retailer inventories in the base period and a lower than average cough, cold and flu season in the current period.
• Fabric and Home Care segment organic sales increased seven percent for the quarter. Fabric Care organic sales increased low single digits driven by innovation, marketing investments, devaluation-related price increases and positive mix from the disproportionate growth of premium forms like fabric enhancer beads. Home Care organic sales increased high teens driven by increased consumer demand for home cleaning products during the pandemic, innovation, increased marketing investments and positive mix due to the disproportionate growth of the North America region.
• Baby, Feminine and Family Care segment organic sales decreased one percent versus year ago. Baby Care organic sales decreased mid-single digits primarily driven by reduction in retailer inventories and competitive activity in the current period and pandemic-related pantry loading in the base period. Feminine Care organic sales decreased low single digits driven by category contraction in certain European markets, partially offset by positive product mix due to premium innovation growth in North America and Greater China. Family Care organic sales increased mid-single digits primarily driven by increased pricing due to lower promotional activity.

Diluted net earnings per share were $1.26, a 13% increase versus the prior year primarily driven by the increase in net sales and an 80 basis-point increase in operating margin. Diluted net earnings per share increased eight percent versus the prior year Core EPS, which excludes non-core restructuring charges in the base period. Currency-neutral net EPS also increased eight percent for the quarter versus the prior year Core EPS.

Reported gross margin increased 130 basis points versus the prior year reported gross margin. Reported gross margin increased 30 basis points versus the prior year core gross margin due to 100 basis points of non-core restructuring charges in the base period. Unfavorable foreign exchange negatively impacted gross margin by 50 basis points. On a currency-neutral basis, reported gross margin increased 80 basis points versus the prior year core gross margin driven by 120 basis points of productivity savings and 80 basis points of benefit from increased pricing, partially offset by 30 basis points negative impact from higher commodity costs and 90 basis points of unfavorable product mix, product reinvestments and other costs. Productivity savings included approximately 80 basis points of headwinds from freight cost increases.

Selling, general and administrative expense (SG&A) as a percentage of sales increased 50 basis points on a reported basis versus the prior year. SG&A as a percentage of sales increased 30 basis points versus the prior year core SG&A due to approximately 20 basis points of lower non-core restructuring charges in the base period. Foreign exchange reduced SG&A by 20 basis points. On a currency-neutral basis, reported SG&A as a percentage of sales increased 50 basis points versus the prior year core SG&A driven by 150 basis points of marketing reinvestments and approximately 110 basis points of inflation and other impacts, partially offset by 120 basis points of sales leverage benefit and 90 basis points of productivity savings from overhead and marketing expenses.

Operating profit margin increased 80 basis points versus the base period reported operating margin. Operating profit margin was unchanged versus the base period core operating margin due to approximately 80 basis points of non-core restructuring charges in the base period. Unfavorable foreign exchange negatively impacted operating margins by 30 basis points. On a currency-neutral basis, reported operating margin increased 30 basis points versus the prior year core operating margin, including total productivity cost savings of 210 basis points for the quarter.

Fiscal Year 2021 Guidance

P&G maintained its outlook for fiscal 2021 all-in and organic sales growth in the range of five to six percent versus the prior fiscal year. Foreign exchange is expected to be roughly neutral to sales growth for the fiscal year.

The Company said it continues to expect fiscal 2021 GAAP diluted net earnings per share growth in the range of eight to ten percent versus fiscal 2020 GAAP EPS of $4.96. GAAP EPS guidance includes non-core charges of $0.16 per share in fiscal 2021 for early debt retirement and of $0.16 per share in fiscal 2020 for incremental restructuring charges. P&G maintained guidance for core earnings per share growth in the range of eight to ten percent versus fiscal 2020 core EPS of $5.12. The Company said its current outlook includes headwinds of approximately $150 million after-tax from foreign exchange impacts and more than $200 million after-tax from higher freight costs. The Company now expects a headwind from commodity costs of approximately $125 million after-tax versus the previous fiscal year.

The Company is not able to reconcile its forward-looking non-GAAP cash flow measure without unreasonable efforts because the Company cannot predict the timing and amounts of discrete cash items, such as acquisitions, divestitures, or impairments, which could significantly impact GAAP results. The Company now estimates fiscal 2021 adjusted free cash flow productivity to be over 100% for the year.

P&G expects to pay more than $8 billion in dividends in fiscal 2021. The Company increased its outlook for common stock repurchase from up to $10 billion to approximately $11 billion in fiscal 2021. Combined, P&G now plans to return about $19 billion of cash to shareowners in this fiscal year.

The Company added that it has started the process of implementing price increases on its Baby Care, Feminine Care and Adult Incontinence product categories in the United States to offset a portion of the impact of rising commodity costs. P&G said the exact amount of the price increase will vary by brand and sub-brand in the range of mid-to-high single digit percentages and will go into effect in mid-September.

Forward-Looking Statements

Certain statements in this release or presentation, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to affect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters, acts of war or terrorism, or disease outbreaks; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials, and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third party information and operational technology systems, networks and services, and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions (including the United Kingdom’s exit from the European Union) and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, intellectual property, labor and employment, antitrust, data protection, tax, environmental, and accounting and financial reporting) and to resolve pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations including maintaining our intended tax treatment of divestiture transactions; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; and (17) the ability to successfully manage the demand, supply, and operational challenges associated with a disease outbreak, including epidemics, pandemics, or similar widespread public health concerns (including the novel coronavirus, COVID-19, outbreak). For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K/A, 10-Q and 8-K reports.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at http://www.pg.com/news.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts)
Consolidated Earnings Information
	Three Months Ended March 31
	2021				2020				% Chg
NET SALES	$	18,109			$	17,214			5%
Cost of products sold	8,922				8,716				2%
GROSS PROFIT	9,187				8,498				8%
Selling, general and administrative expense	5,402				5,045				7%
OPERATING INCOME	3,785				3,453				10%
Interest expense	(106		)		(100		)		6%
Interest income	11				39				(72)%
Other non-operating income, net	187				106				76%
EARNINGS BEFORE INCOME TAXES	3,877				3,498				11%
Income taxes	628				541				16%
NET EARNINGS	3,249				2,957				10%
Less: Net earnings/(loss) attributable to noncontrolling interests	(20		)		40				(150)%
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE	$	3,269			$	2,917			12%
EFFECTIVE TAX RATE	16.2		%		15.5		%
NET EARNINGS PER SHARE (1)
Basic	$	1.30			$	1.15			13%
Diluted	$	1.26			$	1.12			13%
DIVIDENDS PER COMMON SHARE	$	0.7907			$	0.7459
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	2,590.3				2,613.3
COMPARISONS AS A % OF NET SALES									Basis Pt Chg
Gross profit	50.7		%		49.4		%		130
Selling, general and administrative expense	29.8		%		29.3		%		50
Operating income	20.9		%		20.1		%		80
Earnings before income taxes	21.4		%		20.3		%		110
Net earnings	17.9		%		17.2		%		70
Net earnings attributable to Procter & Gamble	18.1		%		16.9		%		120

(1)		Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Consolidated Earnings Information
		Three Months Ended March 31, 2021
		Net Sales		% Change Versus Year Ago		Earnings/(Loss) Before Income Taxes		% Change Versus Year Ago		Net Earnings		% Change Versus Year Ago
Beauty		$3,316		9%		$721		30%		$577		32%
Grooming		1,438		4%		314		3%		256		1%
Health Care		2,356		4%		484		(7)%		377		(8)%
Fabric & Home Care		6,275		8%		1,348		6%		1,027		7%
Baby, Feminine & Family Care		4,604		—%		1,133		—%		871		1%
Corporate		120		N/A		(123)		N/A		141		N/A
Total Company		$18,109		5%		$3,877		11%		$3,249		10%

		Three Months Ended March 31, 2021
Net Sales Drivers (1)		Volume		Organic Volume		Foreign Exchange		Price		Mix		Other (2)		Net Sales
Beauty		2%		2%		2%		2%		3%		—%		9%
Grooming		—%		—%		—%		2%		2%		—%		4%
Health Care		—%		—%		1%		—%		3%		—%		4%
Fabric & Home Care		3%		3%		1%		2%		2%		—%		8%
Baby, Feminine & Family Care		(4)%		(4)%		1%		2%		1%		—%		—%
Total Company		—%		—%		1%		2%		2%		—%		5%

(1)		Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2)		Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Statements of Cash Flows
	Nine Months Ended March 31
Amounts in millions	2021				2020
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD	$	16,181			$	4,239
OPERATING ACTIVITIES
Net earnings	11,444				10,317
Depreciation and amortization	2,025				2,199
Loss on early extinguishment of debt	512				—
Share-based compensation expense	398				325
Deferred income taxes	(167		)		(588		)
Loss/(gain) on sale of assets	(15		)		11
Changes in:
Accounts receivable	(604		)		135
Inventories	(399		)		(533		)
Accounts payable, accrued and other liabilities	1,049				738
Other operating assets and liabilities	(92		)		(58		)
Other	99				51
TOTAL OPERATING ACTIVITIES	14,250				12,597
INVESTING ACTIVITIES
Capital expenditures	(2,073		)		(2,415		)
Proceeds from asset sales	40				28
Acquisitions, net of cash acquired	—				(58		)
Purchases of investments securities	(10		)		—
Proceeds from sales and maturities of investment securities	—				6,151
Change in other investments	—				(2		)
TOTAL INVESTING ACTIVITIES	(2,043		)		3,704
FINANCING ACTIVITIES
Dividends to shareholders	(6,066		)		(5,761		)
Increases/(reductions) in short-term debt	(3,381		)		3,020
Additions to long-term debt	2,429				4,951
Reductions to long-term debt (1)	(4,889		)		(1,534		)
Treasury stock purchases	(8,009		)		(7,405		)
Impact of stock options and other	1,470				1,761
TOTAL FINANCING ACTIVITIES	(18,446		)		(4,968		)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH	65				(179		)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(6,174		)		11,154
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD	$	10,007			$	15,393

(1)		Includes early extinguishment of debt costs of $512 during the nine months ended March 31, 2021.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Condensed Consolidated Balance Sheets
	March 31, 2021				June 30, 2020
Cash and cash equivalents	$	10,007			$	16,181
Accounts receivable	4,861				4,178
Inventories	6,002				5,498
Prepaid expenses and other current assets	1,738				2,130
TOTAL CURRENT ASSETS	22,608				27,987
Property, plant and equipment, net	21,103				20,692
Goodwill	40,612				39,901
Trademarks and other intangible assets, net	23,658				23,792
Other noncurrent assets	8,797				8,328
TOTAL ASSETS	$	116,778			$	120,700
Accounts payable	$	12,134			$	12,071
Accrued and other liabilities	11,109				9,722
Debt due within one year	8,773				11,183
TOTAL CURRENT LIABILITIES	32,016				32,976
Long-term debt	21,053				23,537
Deferred income taxes	5,977				6,199
Other noncurrent liabilities	10,813				11,110
TOTAL LIABILITIES	69,859				73,822
TOTAL SHAREHOLDERS' EQUITY	46,919				46,878
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	116,778			$	120,700

The Procter & Gamble Company

Exhibit 1: Non-GAAP Measures

The following provides definitions of the non-GAAP measures used in Procter & Gamble's April 20, 2021 earnings release and the reconciliation to the most closely related GAAP measures. We believe that these measures provide useful perspective on underlying business results and trends (i.e., trends excluding non-recurring or unusual items) and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measures, but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted. The Company is not able to reconcile its forward-looking non-GAAP cash flow measure because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results.

The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:

Incremental Restructuring: The Company has historically had an ongoing level of restructuring activities. Such activities have resulted in ongoing annual restructuring related charges of approximately $250 - $500 million before tax. Beginning in 2012, the Company has had a strategic productivity and cost savings initiative that resulted in incremental restructuring charges. The adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of restructuring costs. In fiscal 2021 and onwards, the Company expects to incur restructuring costs within our historical ongoing level.

Early debt extinguishment charges: In the three months ended December 31, 2020, the Company recorded after tax charges of $427 million ($512 million before tax) due to early extinguishment of certain long-term debt. These charges represent the difference between the reacquisition price and the par value of the debt extinguished.

We do not view the above items to be part of our sustainable results and their exclusion from Core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation.

Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in assessing achievement of management goals for at-risk compensation.

Core operating profit margin: Core operating profit margin is a measure of the Company's operating margin adjusted for items as indicated. Management believes this non-GAAP measure provides a supplemental perspective to the Company’s operating efficiency over time.

Core gross margin: Core gross margin is a measure of the Company's gross margin adjusted for items as indicated. Management believes this non-GAAP measure provides a supplemental perspective to the Company’s operating efficiency over time.

Core selling, general and administrative (SG&A) expense as a percentage of net sales: Core SG&A expense as a percentage of net sales is a measure of the Company's selling, general and administrative expenses adjusted for items as indicated. Management believes this non-GAAP measure provides a supplemental perspective to the Company’s operating efficiency over time.

Core EPS: Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share adjusted as indicated. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time. This measure is also used when evaluating senior management in determining their at-risk compensation.

Currency-neutral Core EPS growth: Currency-neutral Core EPS growth is a measure of the Company's Core EPS growth versus the prior period excluding the incremental current year impact of foreign exchange. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time.

Free cash flow: Free cash flow is defined as operating cash flow less capital spending. Free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.

Free cash flow productivity and Adjusted free cash flow productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. Adjusted free cash flow productivity is defined as the ratio of free cash flow to net earnings excluding the charges for early debt extinguishment (which are not considered part of our ongoing operations). Management views free cash flow productivity and adjusted free cash flow productivity as useful measures to help investors understand P&G’s ability to generate cash. These measures are used by management in making operating decisions, allocating financial resources and for budget planning purposes. They are also used in assessing the achievement of management goals for at-risk compensation. The Company's long-term target is to generate annual adjusted free cash flow productivity at or above 90 percent.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures
	Three Months Ended March 31, 2021				Three Months Ended March 31, 2020
	AS REPORTED (GAAP)				AS REPORTED (GAAP)				INCREMENTAL RESTRUCTURING (2)				ROUNDING				NON-GAAP (CORE)
COST OF PRODUCTS SOLD	$	8,922			$	8,716			$	(179	)		$	—			$	8,537
GROSS PROFIT	9,187				8,498				179				—				8,677
GROSS MARGIN	50.7		%		49.4		%		1.0		%		—		%		50.4		%
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE	5,402				5,045				26				—				5,071
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES	29.8		%		29.3		%		0.2		%		—		%		29.5		%
OPERATING INCOME	3,785				3,453				153				—				3,606
OPERATING PROFIT MARGIN	20.9		%		20.1		%		0.9		%		(0.1		)%		20.9		%
NET EARNINGS ATTRIBUTABLE TO P&G	3,269				2,917				141				—				3,058
DILUTED NET EARNINGS PER COMMON SHARE (1)	$	1.26			$	1.12			$	0.05			$	—			$	1.17
CURRENCY-IMPACT TO CORE EARNINGS	$	—
CURRENCY-NEUTRAL CORE EPS	$	1.26
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	2,590.3				2,613.3
COMMON SHARES OUTSTANDING - MARCH 31, 2021	2,448.2

(1)		Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
(2)		While total restructuring costs exceeded the historical ongoing level, total restructuring costs included within SG&A for this period were below the historical ongoing level. Accordingly, the non-GAAP adjustment for the SG&A line item adds costs to the comparable GAAP number.

	CHANGE IN CURRENT YEAR REPORTED (GAAP) MEASURES VERSUS PRIOR YEAR NON-GAAP (CORE) MEASURES (1)
	GROSS MARGIN (1)	30		BPS
	SELLING GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES (1)	30		BPS
	OPERATING PROFIT MARGIN (1)	—		BPS
	EPS	8	%
	CURRENCY-NEUTRAL EPS	8	%

(1)		Change versus year ago is calculated based on As Reported (GAAP) values for the three months ended March 31, 2021 versus the Non-GAAP (Core) values for the three months ended March 31, 2020.

Organic sales growth:

January - March 2021	Net Sales Growth		Foreign Exchange Impact		Acquisition & Divestiture Impact/Other (1)		Organic Sales Growth
Beauty	9%		(2)%		—%		7%
Grooming	4%		—%		—%		4%
Health Care	4%		(1)%		—%		3%
Fabric & Home Care	8%		(1)%		—%		7%
Baby, Feminine & Family Care	—%		(1)%		—%		(1)%
Total P&G	5%		(1)%		—%		4%

(1)		Acquisitions/Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.

Total P&G		Net Sales Growth		Combined Foreign Exchange & Acquisition/Divestiture Impact/Other (1)		Organic Sales Growth
FY 2021 (Estimate)		+5% to +6%		-		+5% to +6%

(1)		Acquisitions/Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.

Core EPS growth:

Total P&G		Diluted EPS Growth		Impact of Incremental Non-Core Items (1)		Core EPS Growth
FY 2021 (Estimate)		+8% to +10%		-		+8% to +10%

(1)		Includes net impact of prior year incremental non-core restructuring charges and early debt extinguishment charges in FY2021.

Free cash flow (dollar amounts in millions):

Three Months Ended March 31, 2021
Operating Cash Flow					Capital Spending					Free Cash Flow
$4,087					$(656)					$3,431

Free cash flow productivity (dollar amounts in millions):

Three Months Ended March 31, 2021
Free Cash Flow				Net Earnings				Free Cash Flow Productivity
$3,431				$3,249				106%

Category: PG-IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005629/en/

FAQ

What are Procter & Gamble's Q3 FY21 earnings results?

Procter & Gamble reported Q3 FY21 net sales of $18.1 billion, a 5% increase from the prior year, with diluted EPS of $1.26, a 13% increase.

What is Procter & Gamble's guidance for fiscal year 2021?

P&G maintains an outlook for FY21 sales growth of 5-6% and GAAP diluted EPS growth of 8-10%.

How much cash did Procter & Gamble return to shareholders in Q3 FY21?

In Q3 FY21, Procter & Gamble returned $5 billion to shareholders, which included $2 billion in dividends.

What factors impacted Procter & Gamble's operating margins?

P&G's operating margins were negatively impacted by unfavorable foreign exchange, higher commodity costs, and increased freight costs.